ViaLase uses an image-guided femtosecond laser surgical system for the treatment of glaucoma.
ViaLase
Aliso Viejo, CA
CEO: Tibor Juhasz, PhD
Arboretum Lead: Tim Petersen
ViaLase
IN THE NEWS
ViaLase Closes $40M Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced that it has closed a Series C financing raising gross…
Read More
ViaLase Completes Enrollment for the Pivotal VIA-002 Trial of the ViaLase® Laser to Treat Primary Open Angle Glaucoma
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced it has completed enrollment of VIA-002, the company's pivotal trial of…
Read More
